Magna's Q2 profit rises despite tariffs, industry headwinds
The automotive manufacturer says its net income for the three months ending June 30 was US$379 million, or $1.35 per diluted share, up from US$313 million or $1.09 per share in the same quarter last year.
Earnings worked out to $1.44 per adjusted diluted share, up from $1.35 per share in the same quarter last year.
The mean analyst estimate had been for earnings of $1.14 per share, according to LSEG Data & Analytics.
Chief executive Swamy Kotagiri says the company's results exceeded expectations and reflect ongoing performance initiatives, offsetting industry headwinds including soft volumes in some regions and continued trade policy uncertainty.
Magna says sales totalled US$10.63 billion in the quarter, down from US$10.96 billion in the same quarter last year, as light vehicle production was down six per cent in North America and two per cent in Europe and the company ended production of some programs.
The company's revised outlook for the year shows a dip in overall North American vehicle production but increased output in China, while it boosted its sales outlook by US$400 million to upwards of US$42 billion.
This report by The Canadian Press was first published Aug. 1, 2025.
Companies in this story: (TSX:MG)
The Canadian Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
ISM Manufacturing Survey Shows Faster Contraction; S&P Data Indicate First Downturn of 2025
US manufacturing sector activity contracted at a faster rate sequentially in July, Institute for Sup Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
9 minutes ago
- Yahoo
Costco (COST) Increases Despite Market Slip: Here's What You Need to Know
Costco (COST) closed the most recent trading day at $952.36, moving +1.35% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.6%. On the other hand, the Dow registered a loss of 1.23%, and the technology-centric Nasdaq decreased by 2.24%. Heading into today, shares of the warehouse club operator had lost 4.8% over the past month, lagging the Retail-Wholesale sector's gain of 2.64% and the S&P 500's gain of 2.25%. Investors will be eagerly watching for the performance of Costco in its upcoming earnings disclosure. The company is forecasted to report an EPS of $5.8, showcasing a 12.62% upward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $85.83 billion, up 7.7% from the prior-year quarter. COST's full-year Zacks Consensus Estimates are calling for earnings of $17.97 per share and revenue of $274.97 billion. These results would represent year-over-year changes of +11.55% and +8.06%, respectively. Investors might also notice recent changes to analyst estimates for Costco. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.39% lower. Costco presently features a Zacks Rank of #3 (Hold). Looking at valuation, Costco is presently trading at a Forward P/E ratio of 52.3. This expresses a premium compared to the average Forward P/E of 21.93 of its industry. We can additionally observe that COST currently boasts a PEG ratio of 5.84. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Retail - Discount Stores stocks are, on average, holding a PEG ratio of 2.61 based on yesterday's closing prices. The Retail - Discount Stores industry is part of the Retail-Wholesale sector. Currently, this industry holds a Zacks Industry Rank of 169, positioning it in the bottom 32% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Costco Wholesale Corporation (COST) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates
Flora Growth Corp. (FLGC) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -83.33%. A quarter ago, it was expected that this company would post a loss of $0.01 per share when it actually produced a loss of $0.04, delivering a surprise of -300%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Flora Growth, which belongs to the Zacks Medical - Products industry, posted revenues of $14.8 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 25.71%. This compares to year-ago revenues of $15.68 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Flora Growth shares have lost about 42.9% since the beginning of the year versus the S&P 500's gain of 7.8%. What's Next for Flora Growth? While Flora Growth has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Flora Growth was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.06 on $12.52 million in revenues for the coming quarter and -$0.40 on $47.63 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 26% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Another stock from the same industry, Allurion Technologies, Inc. (ALUR), has yet to report results for the quarter ended June 2025. This company is expected to post quarterly loss of $0.65 per share in its upcoming report, which represents a year-over-year change of -360%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Allurion Technologies, Inc.'s revenues are expected to be $5.95 million, down 49.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Flora Growth Corp. (FLGC) : Free Stock Analysis Report Allurion Technologies, Inc. (ALUR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
